Fig. 5
From: Drug capture materials based on genomic DNA-functionalized magnetic nanoparticles
In vivo results. a Device containing 25 magnets (1 cm × 0.5 cm) with IONP-HN3-DNA coating (above), and the same device after the in vivo experiment (below), demonstrating minimal loss of particles after removal of the device. b Fluoroscopy images during in vivo porcine experiment demonstrating the inferior vena cava with opacified right renal veins (scale bar = 5 mm). The device was placed within the inferior vena cava. The sampling catheters were placed immediately proximal to the device, prior to the renal vein, and distal to the device. c DOX concentration measurements from pre-device, mid-device, post-device, and peripheral locations. d Plasma solutions from the experiment described in c: Left 3, pre-filter samples taken at 1, 3, and 10 min; Center 3, mid-filter samples taken at 1, 3, and 10 min; Right 3, post-filter samples taken at 1, 3, and 10 min
